Why won't Illumina sell Grail? | BioPharma Dive
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Morningstar Utterback. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CVS Health will buy Oak Street Health for about $9.5 billion in cash, joining rivals in adding primary care to its portfolio as pressure mounts on its health insurance business.
CVS Health Corp will buy Oak Street Health Inc for about $9.5 billion in cash, joining rivals in adding primary care to its portfolio as pressure mounts on its health insurance business.